Diamorphine
PreclinicalSmall molecule
Diamorphine is one of 9 small molecule programs targeting Colorectal Surgery. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
8 competitors in Colorectal Surgery
#DrugCompanyPhaseTrials
1MS Contin
HHikma Pharmaceuticals LLC
Approved
Olinvyk
TTrevena Inc.
Approved
Resotran
TakedaPhase 3
IC-Green
PProvepharm SAS
Phase 3
Cyklokapron
JJ Molner
Phase 2
Intravenous Methylene Blue
CChinese University of Hong Kong
Phase 3
Ancef
BBaxter Healthcare Corporation
Preclinical
Senna
MMedtronic - MITG
Preclinical
Diamorphine
YYork Teaching Hospitals NHS Foundation Trust
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Diamorphine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details